Safety and effectiveness of autologous leukocyte-rich platelet-rich plasma therapy (L-PRP therapy) for damage, deficit and prolonged healing in the musculoskeletal system of the human body
Not Applicable
- Conditions
- intractable muscle of damaged tendon attachment and muscle tendon transitiontendonitis, humeral superior condylitis, elbow medial collateral ligament injury, knee medial collateral ligament injury
- Registration Number
- JPRN-UMIN000032134
- Lead Sponsor
- Jikei University Orthopedic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with bacterial infections in the whole body or in areas undergoing this treatment Patients who are suggestive of the possibility of affecting the general condition when infection is caused by this therapy Patients who have a fever of 37 degrees or more without using antipyretics or anti-inflammatory analgesics Patients with open wounds Patients during oral treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self and other senses Clinical laboratory test (blood test Physical findings Visual Analog Scale Sports Reversion Scale
- Secondary Outcome Measures
Name Time Method